Nexcida Therapeutics Overview
- Founded
-
2014
- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
Nexcida Therapeutics General Information
Description
Developer of drugs designed to treat infectious diseases. The company's drugs are helpful in treating infectious disease.
Contact Information
Formerly Known As
North Bridge I
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Primary Office
- 70 Willow Road
- Suite 200
- Menlo Park, CA 94025
- United States
+1 (650) 000-0000
Nexcida Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Out of Business | 01-Aug-2016 | 00.000 | Completed | Out of Business | ||
| 1. Early Stage VC (Series A) | 23-Jun-2015 | 00.000 | 00.000 | 000.00 | Completed | Startup |
Nexcida Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | 00,000,000 | 00.000000 | 00 | 00 | 00 | 00 | 00 | 00.000 |
Nexcida Therapeutics Board Members (5)
| Name | Representing | Role | Since |
|---|---|---|---|
| Brent Ahrens | Nexcida Therapeutics | Board Member | 000 0000 |
| Chen Yu | Nexcida Therapeutics | Board Member | 000 0000 |
| Yigong Ge | Nexcida Therapeutics | Board Member | 000 0000 |